Insiders own 0.87% of the company's stock. About 1.88M shares traded. BioTelemetry, Inc. (NASDAQ:BEAT) has risen 87.79% since January 23, 2017 and is uptrending. The rating was maintained by Cowen & Co with "Market Perform" on Wednesday, January 25. The stock has "Buy" rating by Craig Hallum on Wednesday, September 7.